phase readout
saveNCT05359445: IMA401 TCER® in Recurrent and/or Refractory Solid Tumors, Alone or in Combination With a Checkpoint Inhibitor
ACTIVE_NOT_RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: Immatics Biotechnologies GmbH. Phase: PHASE1. Conditions: Refractory Cancer, Recurrent Cancer, Solid Tumor, Adult, Cancer
view source ↗
comments(0)
5-min edit window · permanent after that